Event Recap

AAV Innovation Summit 2025

Raleigh-Durham, NC

Optimizing genome integrity through AI and vector design

Watch Form Bio and leading experts from industry and academia’s half-day summit on AAV innovation. This exclusive event brought together top minds in gene therapy to explore the latest innovations, challenges and industry trends.

Interested in attending the next AAV Summit? Sign up to be the first to know.

2025 Summit Videos

Speakers

Sebastian Aguirre Kozlouski, PhD

Co-Founder & VP, Platform Development, Carbon Biosciences

Claire Aldridge, PhD

Scientific Advisor & Former Chief Strategy Officer, Form Bio

Brooke Brown, PhD

Scientist, Analytical Development, BridgeBio

Adam Cockrell, PhD

Sr. Director, Vector Biology, Solid Biosciences

Amicia Elliott, PhD

Vice President, Product, Form Bio

Charles Feathers

Sr. Manager, Process Development, Tenaya Therapeutics

Michael Guerrero, PhD

VP, Technical Development & Operations, BridgeBio

Paul Herzich

Chief Technology Officer, Solid Biosciences

Elizabeth Tseng, PhD

Assoc. Dir. Product Marketing, Gene Therapy, PacBio

Fred Porter, PhD

Chief Technical Officer, Taysha Gene Therapies

Anusha Sriraman, PhD

Program Manager, Life Sciences, Form Bio

Phillip Tai, PhD

Assistant Professor, UMass Medical School

Nam Tonthat, PhD

Director, Analytical Sciences, AskBio

Robin Muthig

Sr. Director, Alliance for Regenerative Medicine

Beth Anne Childress, MS, PMP

VP, GMP Quality, AskBio

Jude Samulski, PhD

Alumni Distinguished Professor & Honorary Edward T. Samulski Professor of Medicine, Former Director of UNC Gene Therapy Center & Mentor to the Current Director

Join our newsletter to be notified about the next AAV Summit

Notify Me

Agenda

12:30 PM
Check-in & coffee

1:00 PM
Welcome Remarks

1:10 PM
Keynote: Advancing Gene Therapy from Discovery to Clinical Trials
- Jude Samulski, PhD, Professor & Center Director at University NC, Chapel Hill

1:40 PM
Understanding AAV Vector Genome Heterogeneity
- Phil Tai, PhD, Associate Professor, UMass Chan Medical

2:05 PM
Biophysical & Molecular Characterization of rAAV Species
- Brooke Brown, PhD, Scientist, Analytical Development, BridgeBio

2:25 PM
Designing rAAV Vectors Using In Silico Vector Modeling
- Adam Cockrell, PhD, Sr. Director, Vector Biology, Solid Biosciences

2:45 PM
Networking Break

3:00 PM
AI & In Silico Tools for Faster, More Predictable AAV Development
- Amicia Elliott, PhD, Vice President, Product, Form Bio

3:20 PM
Challenges around Gene Therapy Manufacturing
- Fred Porter, PhD, CTO, Taysha Gene Therapies

3:40 PM
AAV Working Group Panel: Standardizing & Reporting for Long-Read NGS & Analysis for rAAV Vectors
- Moderator: Anusha Sriraman, PhD, Program Manager, Life Sciences, Form Bio
- Brooke Brown, PhD, Scientist, Analytical Development, BridgeBio
- Adam Cockrell, PhD, Sr. Director, Vector Biology, Solid Biosciences
- Charles Feathers, Sr. Manager, Process Development, Tenaya Therapeutics
- Nam Tonthat, PhD, Director Analytical Sciences, AskBio
- Elizabeth Tseng, PhD, Assoc. Dir. Product Marketing, Gene Therapy, PacBio

4:10 PM
Gene Therapy State-of-the-Industry
- Robin Muthig, Sr. Director, Membership, Alliance for Regenerative Medicine

4:30 PM
Executive Panel: From Innovation to Impact—Advancing Gene Therapy Development & Commercialization
- Moderator: Claire Aldridge, PhD, Scientific Advisor & Former Chief Strategy Officer, Form Bio
- Sebastian Aguirre Kozlouski, PhD, Co-Founder & VP, Platform Development, Carbon Biosciences
- Michael Guerrero, PhD, VP Technical Development & Operations, BridgeBio
- Paul Herzich, Chief Technology Officer, Solid Biosciences
- Beth Anne Childress, MS, PMP - VP, GMP Quality, AskBio
- Fred Porter, PhD, CTO, Taysha Gene Therapies

5:00 PM
Networking Reception

Areas of Focus

Utilizing long-read sequencing for AAV Genome Integrity Analysis

Advancing long-read sequencing analysis with open-source tools (bioRxiv publication)

Leveraging AI and in silico tools to accelerate AAV Gene Therapy Development

Who Should Attend?

Executives who work in AAV gene therapy sector

Scientists who work in AAV therapeutic development, including preclinical and manufacturing

AAV Resource Hub

Explore best practices, tools and standards in AAV research and development

Visit the Hub